1. Home
  2. Labeler Index
  3. Ferring Pharmaceuticals Inc.
  4. 55566-6700
  5. NDC Package Code: 55566-6700-1 Clenpiq

NDC Package 55566-6700-1 Clenpiq

Sodium Picosulfate,Magnesium Oxide,And Anhydrous Citric Acid Liquid Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55566-6700-1
Package Description:
2 BOTTLE in 1 CARTON / 160 mL in 1 BOTTLE (55566-6700-0)
Product Code:
55566-6700
Proprietary Name:
Clenpiq
Non-Proprietary Name:
Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid
Substance Name:
Anhydrous Citric Acid; Magnesium Oxide; Sodium Picosulfate
Usage Information:
Sodium picosulfate/magnesium oxide/citric acid solution is used to clean out the intestines before surgery or certain procedures (such as colonoscopy, X-rays). It is a laxative that works by drawing large amounts of water into your intestines and stimulating the colon. This causes watery bowel movements (diarrhea). Clearing stool from the intestines helps your doctor to better examine the inside of your colon.
11-Digit NDC Billing Format:
55566670001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1991509 - CLENPIQ 10 MG / 3.5 GM / 12 GM in 160 mL Oral Solution
  • RxCUI: 1991509 - citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML Oral Solution [Clenpiq]
  • RxCUI: 1991509 - CLENPIQ (citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG) per 160 ML Oral Solution
  • RxCUI: 1994540 - picosulfate sodium 10 MG / magnesium oxide 3.5 GM / citric acid 12 GM in 160 mL Oral Solution
  • RxCUI: 1994540 - citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML Oral Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ferring Pharmaceuticals Inc.
    Dosage Form:
    Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ANHYDROUS CITRIC ACID 12 g/160mL
  • MAGNESIUM OXIDE 3.5 g/160mL
  • SODIUM PICOSULFATE 10 mg/160mL
    • Pharmacologic Class(es):
  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Increased Large Intestinal Motility - [PE] (Physiologic Effect)
  • Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
  • Osmotic Activity - [MoA] (Mechanism of Action)
  • Osmotic Laxative - [EPC] (Established Pharmacologic Class)
  • Stimulant Laxative - [EPC] (Established Pharmacologic Class)
  • Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    NDA209589
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-29-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55566-6700-1?

    The NDC Packaged Code 55566-6700-1 is assigned to a package of 2 bottle in 1 carton / 160 ml in 1 bottle (55566-6700-0) of Clenpiq, a human prescription drug labeled by Ferring Pharmaceuticals Inc.. The product's dosage form is liquid and is administered via oral form.

    Is NDC 55566-6700 included in the NDC Directory?

    Yes, Clenpiq with product code 55566-6700 is active and included in the NDC Directory. The product was first marketed by Ferring Pharmaceuticals Inc. on June 29, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 55566-6700-1?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 55566-6700-1?

    The 11-digit format is 55566670001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-155566-6700-15-4-255566-6700-01